Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)
Go back to Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)| ENDOCYTE (NASDAQ: ECYT) | Delayed: 23.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.99 | 52 Week High | $4.89 | |||
| Open | $25.06 | 52 Week Low | $2.62 | |||
| Day High | $23.99 | P/E | N/A | |||
| Day Low | $23.99 | EPS | $-0.44 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 122.22 +3.13 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.09 | 52 Week High | $65.46 | |||
| Open | $120.04 | 52 Week Low | $47.97 | |||
| Day High | $122.71 | P/E | 83.14 | |||
| Day Low | $119.95 | EPS | $1.47 | |||
| Volume | 8,469,209 | |||||
